science top stories popular news  

Daily non-political popular news in brief.

New clinical data shows chromium picolinate improves cognitive function

12-13-2007 · EurekAlert!

Nutrition 21, Inc., a leading developer and marketer of chromium-based and omega-3 fish oil-based nutritional supplements, today announced the results of a clinical study that showed daily supplementation with 1000 mcg of chromium as chromium picolinate improved cognitive function in older adults experiencing early memory decline. The results of the randomized, double-blind, placebo-controlled study were presented to the medical community at a neurological meeting.

Read more »

Keywords: clinical, data, shows, chromium, picolinate, improves, cognitive, function, show, improve

« Previous | Next »

Similar news on "New clinical data shows chromium picolinate improves cognitive function":

  1. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
    06-04-2007 · EurekAlert!
    Nutrition 21 Inc. today announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).
    Similar news · Read more »
  2. Published study shows benefits of Diachrome for people with type 2 diabetes
    01-08-2007 · EurekAlert!
    Nutrition 21, Inc., today announced the results of a recent placebo controlled, double-blind, randomized, single center study that demonstrated that Diachrome®, a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes.
    Similar news · Read more »
  3. The embodied self: Using virtual reality to study the foundations of bodily self-consciousness
    08-23-2007 · EurekAlert!
    A group of neuroscientists and a philosopher have devised a series of novel experiments using virtual reality that could shed light on decades of clinical data pointing to cognitive and perceptual mechanisms involved in humans' concept of self. Their results, published Aug. 23 in Science magazine, show that a person's sense of self can be manipulated using conflicting multisensory bodily input, indicating that spatial unity and bodily self-consciousness depend on brain mechanisms, and can be explored experimentally.
    Similar news · Read more »
  4. Pulmonary hypertension patients improve from combination therapy
    12-01-2006 · EurekAlert!
    For patients with pulmonary arterial hypertension (PAH), adding inhaled iloprost to treatment with bosentan -- two different classes of drugs often used individually to treat PAH -- increases exercise capability, reduces clinical deterioration and, in some cases, improves diagnostic functional class by one stage.
    Similar news · Read more »
  5. Genesearch Breast Lymph Node assay detects breast cancer metastases with greater sensitivity
    12-16-2006 · EurekAlert!
    Results from a prospective clinical study show that the GeneSearch™ Breast Lymph Node (BLN) Assay, a gene-based diagnostic test has greater sensitivity than traditional intra-operative methods of detecting the spread of breast cancer to the lymph nodes. In the study sponsored by Veridex, LLC, the GeneSearch™ BLN Assay demonstrated overall sensitivity at least 10 percentage points higher than traditional intra-operative tests. The data were presented today at the 29th annual San Antonio Breast Cancer Symposium.
    Similar news · Read more »
  6. UCSF brain tumor vaccine trial shows promising results
    04-16-2007 · EurekAlert!
    A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco.
    Similar news · Read more »
  7. Anyone can save a life: Penn researchers lead national efforts to improve CPR quality
    01-14-2008 · EurekAlert!
    Studies show that only 15 to 30 percent of sudden cardiac arrest victims receive bystander CPR before emergency personnel arrive. But chances for survival plummet as minutes tick by without any blood circulating through the body. Early bystander CPR, however, doubles to triples survival rates. Penn doctors are using a multi-pronged approach, combining new technology with best clinical practices, to boost CPR quality in the community and across the nation.
    Similar news · Read more »
  8. Children with gene show reduced cognitive function
    11-05-2007 · EurekAlert!
    Children possessing a gene known to increase Alzheimer's disease risk already show signs of reduced cognitive function, an Oregon Health & Science University study has found. Scientists discovered that 7- to 10-year-olds with a member of a family of genes implicated in development, nerve cell regeneration and neuroprotection display reduced spatial learning and memory, associated with later-life cognitive impairments. This suggests brain changes predisposing a person to Alzheimer's might occur much sooner than previously thought.
    Similar news · Read more »
  9. Innovative satellite system proves worth with better weather forecasts, climate data
    12-11-2006 · EurekAlert!
    Preliminary findings from a revolutionary satellite system launched earlier this year show that the system can boost the accuracy of forecasts of hurricane behavior, significantly improve long-range weather forecasts, and monitor climate change with unprecedented accuracy. There will be a press conference/teleconference at 5 p.m. Eastern Time today.
    Similar news · Read more »
  10. VEGF Trap shows activity in patients with advanced ovarian cancer
    06-02-2007 · EurekAlert!
    Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. The findings, which are being presented today at the American Society of Clinical Oncology’s annual meeting, may indicate a role for this targeted therapy in women with ovarian cancer who have exhausted all other options.
    Similar news · Read more »